The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a recurrent abdominal incisional hernia.
It was reported that after underlay implant, the patient experienced severe pain, hernia recurrence, inflammation, meshoma, infection, debridement; dense adhesions, enterocutaneous fistula, scarring, abdominal wall cellulitis, draining sinus, necrotic tissue, and mesh eroding into small bowel.
Post-operative patient treatment included removal surgery.
|